More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year.
The post Is Medtronic On the Cusp of Rewriting the Story of Renal Denervation? appeared first on MedCity News.
